Keyphrases
Left Ventricular Noncompaction
100%
Gene Variants
34%
Kawasaki Disease
33%
Dilated Cardiomyopathy
26%
Sarcomere Genes
26%
Next-generation Sequencing
24%
Congestive Heart Failure
20%
Cardiomyopathy
16%
Neonate
16%
Pediatric Patients
16%
Systematic Meta-analysis
16%
Pathogenic Variants
13%
Genotype-phenotype Correlation
13%
Echocardiographic
12%
Heart Failure
12%
Clinical Significance
12%
Genetic Variants
12%
Vasculitis
12%
Fetal Onset
11%
Congenital Heart Disease
11%
Interleukin-1β
11%
Juvenile Type
11%
Inflammatory Activity
11%
Human Coronary Artery Endothelial Cells
11%
S100A12
11%
Monocyte-derived Cells
11%
T-box
11%
TBX5
11%
Ion Channel Genes
11%
Left Ventricular Non-compaction Cardiomyopathy
11%
Hypertensive Hydrocephalus
11%
Pediatric Case Report
11%
RVSV
11%
Tafazzin
11%
MicroRNA-145-5p
11%
Endothelial Microparticles
11%
MicroRNA-320a
11%
Chronic Myocarditis
11%
Long-term Prognosis
11%
Variant Phenotypes
11%
Three-dimensional Echocardiography
11%
Right Ventricular Function
11%
Left Ventricular Function
11%
Meta-analysis
11%
Early Infancy
11%
MYH7
10%
Trabeculation
10%
TPM1
9%
Poor Prognosis
9%
Tricuspid Annular Plane Systolic Excursion (TAPSE)
8%
Medicine and Dentistry
Noncompaction Cardiomyopathy
83%
Congestive Heart Failure
34%
Myocardial Disease
21%
Next Generation Sequencing
20%
Sarcomere
18%
Dilated Cardiomyopathy
18%
Kawasaki Disease
16%
Neonate
16%
Persistent Truncus Arteriosus
16%
Pediatrics Patient
16%
Infancy
14%
MYH7
12%
Echocardiography
12%
Coronary Artery
11%
Interleukin 1
11%
Hydrocephalus
11%
Endothelial Cell
11%
Pediatrics
11%
Three Dimensional Echocardiography
11%
Tafazzin
11%
Genotype Phenotype Correlation
11%
Right Ventricular Function
11%
Systolic Function
10%
Ejection Fraction
9%
Cardiac Dysrhythmia
8%
Brain Natriuretic Peptide
8%
Hypoplasia
8%
End-Diastolic Volume
8%
Electrocardiogram
7%
Stroke Volume
7%
End-Systolic Volume
7%
Clinical Feature
6%
Beta Adrenergic Receptor Blocking Agent
5%
Diastolic Function
5%
Pooled Analysis
5%
Gestational Diabetes
5%
Systematic Review
5%
Adverse Event
5%
Left Ventricular Hypertrophy
5%
Tachycardia-Induced Cardiomyopathy
5%
Heart Function
5%
Lung Congestion
5%
Patient with Kawasaki Disease
5%
